Press Releases CanSino Biologics Inc.

Equities

6185

CNE100003F01

Market Closed - Hong Kong S.E. Other stock markets 04:08:24 2024-06-06 am EDT			5-day change	1st Jan Change
21.65 ^HKD	0.00%		+2.36%	-8.07%

May. 31	CanSino Biologics Inc. Announces Resignation of Nisa Bernice Wing-Yu LEUNG as Non-Executive Director and Member of the Nomination Committee	CI
May. 21	Cansino Biologics Invests 160 Million Yuan in China Bohai Bank’s Structured Deposits	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CanSinoBIO CSO Shares the Latest Results of the Company's Globally Innovative Pneumococcal Vaccine	Apr. 29	AQ
CanSinoBIO CSO Shares Latest Results of the Company's Globally Innovative Pneumococcal Vaccine	Apr. 26	AQ
The Commercialization of Asia's First Meningococcal Conjugate Vaccine From CanSinoBIO Represents a Significant Breakthrough	Mar. 27	AQ
CanSino Biologics : CanSinoBIO Initiates Phase Ⅲ Clinical Trial of Group ACYW135 Meningococcal Conjugate Vaccine Menhycia® in Indonesia	Mar. 24	PU
CanSino Biologics : CanSinoBIO and SPIMACO Forge Strategic Partnership to Advance Accessibility of Cutting-Edge Vaccines	Dec. 18	PU
CanSino Biologics : CanSinoBIO Kicks-off the Polio VLP Vaccine Cooperation	Dec. 04	PU
CanSino Biologics : CanSinoBIO's Convidecia Air® Receives Approval in Indonesia	23-03-01	PU
CanSino Biologics : Latest Study Shows Encouraging Results of CanSinoBIO’s mRNA COVID-19 Vaccine as Heterologous Booster	23-02-19	PU
CanSino Biologics : Solution Group Berhad to Start Local Fill and Finish of CanSinoBIO’s COVID-19 Vaccine in Malaysia	23-02-12	PU
CanSino Biologics : CanSinoBIO Announces Encouraging Clinical Progress of its COVID-19 mRNA Vaccine	23-01-06	PU
First Overseas Shipment of CanSinoBIO’s Convidecia Air™ Delivered to Morocco	22-12-30	AQ
CanSino Biologics : First Overseas Shipment of CanSinoBIO’s Convidecia Air™ Delivered to Morocco	22-12-28	PU
CanSino Biologics : CanSinoBIO Leads Sino-Indonesian Collaboration on Mucosal Vaccine Development	22-11-17	PU
CanSino Biologics : CanSinoBIO’s Convidecia Air™ Approved for Emergency Use in Morocco	22-11-10	PU
CanSino Biologics : and AstraZeneca Sign Strategic Collaboration Agreement to Deepen Research on Rare Diseases	22-11-10	PU
CanSino Biologics : Celebrates the Rollout of the Inhaled Vaccine, Convidecia Air™, in Shanghai	22-10-25	PU
CanSino Biologics : CanSinoBIO to Present Latest Data on Convidecia Air™ at the World Vaccine Congress Europe 2022	22-10-06	PU
CanSino Biologics : CanSinoBIO's Convidecia Air™ Receives Approval in China	22-09-04	PU
CanSino Biologics : Convidecia Air™ Receives Clinical Trial Approval in Malaysia	22-08-18	PU
CanSinoBIO's COVID-19 Vaccine Convidecia™ Receives WHO Emergency Use Listing	22-05-19	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

INTERVIEW - Xuefeng Yu, CEO of CanSino Biologics: Behind the scenes of the agreement with AstraZeneca

August 31, 2023 at 06:08 am EDT